Astellas
Astellas Oncology Research is seeking a highly motivated scientist to join the Antibody-Drug Conjugates (ADC) Group, contributing to the design, conjugation, purification, and characterization of next-generation bioconjugate therapeutics. The role involves developing and optimizing conjugation processes, troubleshooting technical challenges, and collaborating with cross-functional teams to advance the oncology pipeline. This position requires expertise in bioconjugation chemistries and protein purification to support the delivery of transformative therapies to patients.
Astellas is a global life sciences company headquartered in Tokyo, Japan, committed to turning innovative science into value for patients through transformative therapies. The company operates in more than 70 countries and focuses on disease areas including oncology, ophthalmology, urology, immunology, and women's health. Through its research and development programs, Astellas pioneers new healthcare solutions in areas with high unmet medical need.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Astellas.
9% above the average for this role
Scientist, Bioconjugation
Dyne Therapeutics
Senior Scientist, Bioconjugation
AstraZeneca
Senior Scientist, Protein and Antibody Bioconjugation
lifelancer
Sr. Scientist, Protein and Antibody Bioconjugation
Neurocrine Biosciences
TEMP - Scientist, Bioconjugation Purification
Neurocrine Biosciences
Scientific Director, Bioconjugation Development
lifelancer